Looking at how NVIV has been trading over the past couple of months since the the stock sale, bottoming near $1.00, I think that the only thing that will move the stock upward is the 1st patient enrollment in the trial.
All those other items, while they might be positive, will not move NVIV significantly up.
My thought in making the statement about why the stock is moving was to see if anyone had news of the 1st patient. I believe that is why most investors are invested here, and they are eagerly awaiting news.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.